The in vitro Secondary Pharmacology Lead is responsible for in vitro Secondary Pharmacology activities supporting the people, portfolio, innovation and productivity goals of DSRD and WRDM. This position provides strong leadership to the in vitro Secondary Pharmacology group encouraging an environment that enables colleagues to fully contribute, models the Pfizer Leadership Behaviors and Values and embeds a rewarding scientific climate. The in vitro Secondary Pharmacology Lead develops strategic direction for the in vitro Secondary Pharmacology area (science, technology, strategy, operations, etc...) and is accountable for implementation and execution of initiatives. The in vitro Secondary Pharmacology Lead is also responsible for review and approval of all aspects of in vitro Secondary Pharmacology work including study design, data interpretation, report writing, study finalization, and responses to regulatory and team inquiries. There will also be an external leadership component to 'influence the external environment' (e.g. regulatory guidance and evolving scientific thinking).
May provide management of DSRD Outsourced studies, including protocol development, monitoring, study conduct and adherence to the protocol and Pfizer expectations, appropriately communicating and reviewing study updates, reviewing and approving of reports, and partnering with DSRD Team Leads (DSTL) and/or other team representatives to monitor project related milestones.
May serve as Study Director and be responsible for protocol development, design, conduct, data interpretation and reporting of exploratory, mechanistic and/or GLP studies in accordance with the regulatory definitions of a Study Director when appropriate.
The in vitro Secondary Pharmacology Lead is responsible, as a member of the Global Toxicology extended leadership team, for enabling and supporting the DSRD business model to deliver the WRD portfolio and provide value to DSRD, WRDM and Pfizer.ROLE RESPONSIBLITIES
- Develop and lead the in vitro Secondary Pharmacology group so as to maintain a highly motivated, productive and innovative discipline that builds on best practices to improve the strategies and tactics associated with this work area.
- Responsible for developing strategies to improve the overall quality of in vitro Secondary
- Pharmacology work conducted both internally or at CROs.
- Provides primary point of contact for other DSRD and WRDM lines for all interfaces related to in vitro Secondary Pharmacology activities and strategies.
- May serve as Study Director
- Responsible for oversight of all phases of outsourced studies (study enabling, study setup, in-life, and reporting). Responsible for partnering with DSRD DSTLs and SMEs to ensure study milestones are appropriately timed and meet necessary scientific and regulatory requirements. Responsible for participating in on-site monitoring of study activities at CRO sites and CRO qualifications as needed. Provides input/feedback to Line Management, Outsourcing, and CRO staff on issue resolution, best practices and opportunities for improving activities and relationships
- Participates in review of draft research reports to ensure quality and consistency.
- Participates, as needed, as a Drug Safety Team Lead (DSTL), maximum 40%.
- Participates, as needed, to global efforts or teams ensuring the quality and continuous improvement.
- Influences the internal and external environment in the Secondary Pharmacology discipline
- Ph.D. or D.V.M., or equivalent experience, with relevant experience in the Pharmaceutical industry, 5 years
- Deep knowledge in all aspects of Secondary Pharmacology and strong scientific skills
- Track record of strategic thinking and leading and motivating teams is essential
- Preferred Previous Experience:
- Demonstrated capability with relevant experience.
- Demonstrated ability to work collaboratively, lead, and manage in a matrixed, multi-line environment
Other Job Details:
Relocation support availableLast day to apply: February 7, 2023
Relocation assistance may be available based on business needs and/or eligibility.
\nPfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative. EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Research and Development